Next-Generation Sequencing Market

The Next-Generation Sequencing (NGS) market encompasses highly parallelized, high-throughput technologies used to determine nucleotide sequences. Key customers include healthcare institutions, academic researchers, and biotechnology and pharmaceutical firms. The market's growth is driven by increased adoption in clinical diagnostics, continuous improvements in the speed, accuracy, and cost-effectiveness of the technology, and its expanding applications in drug discovery and personalized medicine.